Last mentioned: Mar 23, 2026
Citi PT Reduction
Citi lowers its price target for GEHC, citing sector-wide headwinds.
Leadership Change
SEC filing details departure and election of directors and officers.
SNB Position
Swiss National Bank reports a $99.12 million stake in the company.
Analyst Consensus
Market analysts set a price target of $92.50 for GEHC stock.
Material Agreement
Company enters into a material definitive agreement regarding financial obligations.
Quarterly Earnings
GE HealthCare reports results of operations and financial condition.
Citi has lowered its price target for GE HealthCare Technologies (GEHC) following a series of leadership changes and a broader reassessment of hospital capital expenditure trends. The move reflects a more cautious stance on the medical technology sector as providers navigate persistent inflationary pressures and budget constraints.
Citi has lowered its price target for GE HealthCare Technologies (GEHC), signaling a cautious outlook on the medical imaging giant's near-term growth trajectory. The adjustment reflects broader sector concerns regarding capital equipment spending and regional market volatility in the healthcare technology space.